Elena Smolyarchuk, principal investigator for the clinical trial of a COVID-19 vaccine, announced the completed study, and the team has declared to Russian press that the safety of the experimental product has been established. This reports the head of Sechenov University’s Center for Clinical Research as volunteer participants were discharged from the research site on July 15 and July 20. Some press is announcing that Russia is the first nation to finish human trials for a COVID-19 vaccine. How could that be when they just announced preliminary safety studies in June? The answer is that it’s propaganda, also known as “fake news.” Its good news that preliminary safety trials for yet another vaccine in the world demonstrates positive results. The more safe and effective vaccines the world has the better. However, its disingenuous to declare the entire vaccine is ready after a one month study involving under 100 participants.
Sechenov University’s Center for Clinical Research led this study of the vaccine developed by Russia’s Gamaelya Research Institute on June 18, 2020. In another media source, Alexander Lukashev, director of the institute of Medica...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).